← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Argolyn Bioscience, Inc.
Durham, NC
$1,774,146
Total funding
4
Grants
Funding over time
peak $641K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$1,774,146 · 4
By mechanism
R44$1,345,456 · 1
R41$264,745 · 2
R43$163,945 · 1
Investigators at Argolyn Bioscience, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel Neurotensin Analogs as Antischizophrenics$477,047
R44 · FY2006 · MH
Novel Neurotensin Analogs as Antischizophrenics$475,884
R44 · FY2005 · MH
Novel Neurotensin Analogs as Antischizophrenics$392,525
R44 · FY2007 · MH
Development of Neurotensin-based Analgesics$163,945
R43 · FY2006 · GM
Novel Neurotensin Analogs as Antischizoprenics$139,466
R41 · FY2002 · MH
NON-NATURAL AMINO ACIDS IN PEPTIDE DRUG DEVELOPMENT$125,279
R41 · FY2002 · DA